Pfizer Inc.'s cholesterol drug Lipitor, the world's best sel

UNITED STATES - JULY 22: Pfizer Inc.'s cholesterol drug Lipitor, the world's best selling drug, center, and Pfizer's Norvasc blood pressure medicine, right, are arranged for a photo with the Wyeth depression treatment Effexor, left, and Wyeth's Protonix acid reflux medicine at New London Pharmacy in New York, U.S., on Wednesday, July 22, 2009. Pfizer Inc., the world's biggest drugmaker, raised its earnings forecast and said profit fell less than analysts expected as job cuts offset falling revenue from Lipitor and Norvasc. (Photo by Jb Reed/Bloomberg via Getty Images)
UNITED STATES - JULY 22: Pfizer Inc.'s cholesterol drug Lipitor, the world's best selling drug, center, and Pfizer's Norvasc blood pressure medicine, right, are arranged for a photo with the Wyeth depression treatment Effexor, left, and Wyeth's Protonix acid reflux medicine at New London Pharmacy in New York, U.S., on Wednesday, July 22, 2009. Pfizer Inc., the world's biggest drugmaker, raised its earnings forecast and said profit fell less than analysts expected as job cuts offset falling revenue from Lipitor and Norvasc. (Photo by Jb Reed/Bloomberg via Getty Images)
Pfizer Inc.'s cholesterol drug Lipitor, the world's best sel
ACHETER UNE LICENCE
Comment puis-je utiliser cette image ?
385,00 €
EUR
Getty ImagesPfizer Inc.'s cholesterol drug Lipitor, the world's best sel, Photo d'actualitéPfizer Inc.'s cholesterol drug Lipitor, the world's best sel, Photo d'actualitéPfizer Inc.'s cholesterol drug Lipitor, the world's best sel Obtenez des photos d'actualité haute résolution de qualité sur Getty ImagesProduct #:94965544
475€175€
Getty Images
In stock

INFORMATIONS

Restrictions :
Contactez votre agence locale pour toute utilisation commerciale ou promotionnelle.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg’s prior written consent.
Crédits :
Bloomberg / Contributeur
Editorial - n° :
94965544
Collection :
Bloomberg
Date de création :
22 juillet 2009
Date de chargement :
Type de licence :
Droits gérés
Infos autorisations :
Autorisation non disponible. Plus d'infos
Source :
Bloomberg
Référence :
pdir1190\PHi_j0071.JPG